Evidence map›Paper›PMID 33391482›Full record

ArticleTheranostics2021

Progenitor cell-derived exosomes endowed with VEGF plasmids enhance osteogenic induction and vascular remodeling in large segmental bone defects.

Yao Zha, Yawu Li, Tianyi Lin, Jia Chen, Shengmin Zhang, Jianglin Wang

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 2 pooled it
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 2 syntheses or guidelines pooled it, 220 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Extracellular Vesicles and Their Role in Osteogenesis.Bioengineering (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Nano-Based 3D Printed Scaffold for Bone Tissue Engineering.Bioengineering (Basel, Switzerland) · 2026
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yao ZhaAdvanced Biomaterials and Tissue Engineering Center,Huazhong University of Science and Technology, Wuhan, 430074, P. R. China.
Yawu LiAdvanced Biomaterials and Tissue Engineering Center,Huazhong University of Science and Technology, Wuhan, 430074, P. R. China.
Tianyi LinAdvanced Biomaterials and Tissue Engineering Center,Huazhong University of Science and Technology, Wuhan, 430074, P. R. China.
Jia ChenAdvanced Biomaterials and Tissue Engineering Center,Huazhong University of Science and Technology, Wuhan, 430074, P. R. China.
Shengmin ZhangAdvanced Biomaterials and Tissue Engineering Center,Huazhong University of Science and Technology, Wuhan, 430074, P. R. China.
Jianglin WangAdvanced Biomaterials and Tissue Engineering Center,Huazhong University of Science and Technology, Wuhan, 430074, P. R. China.
Huazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large segmental bone regeneration remains a great challenge due to the lack of vascularization in newly formed bone. Conventional strategies primarily combine bone scaffolds with seed cells and growth factors to modulate osteogenesis and angiogenesis. Nevertheless, cell-based therapies have some intrinsic issues regarding immunogenicity, tumorigenesis, bioactivity and off-the-shelf transplantation. Exosomes are nano-sized (50-200 nm) extracellular vesicles with a complex composition of proteins, nucleic acids and lipids, which are attractive as therapeutic nanoparticles for disease treatment. Exosomes also have huge potential as desirable drug/gene delivery vectors in the field of regenerative medicine due to their excellent biocompatibility and efficient cellular internalization.

Indexed as

AnimalsBone and BonesBone RegenerationCell AdhesionCell LineCell ProliferationExosomesMaleMaterials TestingMiceOsteogenesisPlasmidsPolyestersPrinting, Three-DimensionalRadiusRatspolycaprolactonePolyestersVascular Endothelial Growth Factor A3D printinganchor peptideengineered exosomevascularized osteogenesisVEGF gene

Identifiers

PMID33391482
PMCPMC7681080
OpenAlexW3095185855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.